| |
 |
Orchid Chemicals & Pharmaceuticals
Ltd
|
|
Unaudited Financial Results for three months
ended June 30, 2003
|
| |
|
|
|
(Rs.Lakhs)
|
| Sl No |
Particulars |
Three months ended
June 30, 2003
(Unaudited)
|
Three months ended
June 30, 2002
(Unaudited)
|
Year ended March 31, 2003
(Audited)
|
|
1
|
Sales and Operating Income |
17292.07
|
10683.50
|
54141.43
|
|
2
|
Other Income |
49.89
|
2.60
|
111.38
|
|
3
|
Total Expenditure |
14033.28
|
8477.70
|
43289.70
|
|
|
a) Decrease/(Increase) in Stock
in trade |
(1176.04)
|
(131.22)
|
(4702.99)
|
|
|
b) Consumption of raw materials |
10567.38
|
5570.54
|
31910.92
|
|
|
c) Staff Cost |
960.41
|
729.01
|
3403.16
|
|
|
d) Other Expenditure |
3681.53
|
2317.37
|
12678.61
|
|
4
|
Profit before Interest, Depreciation & Tax
(1+2-3)
|
3308.68
|
2208.40
|
10963.11
|
|
5
|
Interest and Finance Charges |
1108.70
|
756.62
|
4207.69
|
|
6
|
Depreciation |
1380.06
|
1022.76
|
4030.71
|
|
7
|
Profit before tax (4-5-6) |
819.92
|
429.02
|
2724.71
|
|
8
|
Provision for Taxation |
63.09
|
138.27
|
770.65
|
|
9
|
Net Profit (7-8) |
756.83
|
290.75
|
1954.06
|
|
10
|
Paid- up Equity Share Capital
(Face value of Rs. 10 each) |
3238.19
|
2799.92
|
3238.19
|
|
11
|
Reserves excluding Revaluation
Reserves |
|
|
36990.13
|
|
12
|
Basic & Diluted Earnings per
Share (Rs.) |
2.34*
|
1.04*
|
6.61
|
| * EPS is for the period (not annualised) |
|
|
| |
|
|
|
|
| SEGMENT WISE REVENUE, RESULTS AND
CAPITAL EMPLOYED |
|
|
(Rs.Lakhs)
|
| Particulars |
Three months ended
June 30, 2003
|
Three months ended
June 30, 2002
|
Year ended
March 31, 2003
|
| 1. Segment Revenue |
|
|
|
| a. Bulk |
15302.69
|
9724.73
|
50066.25
|
| b. Formulations |
2781.73
|
1186.51
|
6346.07
|
| Total |
18084.42
|
1091.24
|
56412.32
|
| Less: Inter segment revenue |
792.35
|
227.74
|
2270.89
|
| Net Sales / Income from Operations |
17292.07
|
10683.50
|
54141.43
|
| |
|
|
|
| 2. Segment Results |
|
|
|
| a. Bulk |
1641.52
|
1196.60
|
7315.15
|
| b. Formulations |
237.21
|
(13.56)
|
(452.40)
|
| Total |
1878.73
|
1183.04
|
6862.75
|
| Less: |
|
|
|
| i) Interest (Net) |
1108.70
|
756.62
|
4207.69
|
| ii) Other unallocable expenditure
net of unallocable income |
(49.89)
|
(2.60)
|
(69.65)
|
| Total Profit Before Tax |
819.92
|
429.02
|
2724.71
|
| |
|
|
|
| 3. Capital Employed |
|
|
|
| a. Bulk |
102305.04
|
76741.71
|
98935.81
|
| b. Formulations |
9587.21
|
2823.36
|
9350.00
|
| Total |
111892.25
|
79565.07
|
108285.81
|
| |
- The above financial results were taken on record by the
Board of Directors at its meeting held on Thursday, July
24, 2003.
- Previous period figures have been regrouped, wherever
necessary.
- The provisions of Income Tax Act, 1961 relating to EOU's
have been amended on May 8, 2003. Pursuant to this, the
deferred tax iability for the quarter has been adjusted
against deferred tax assets available.
- The Company received 20 complaints during the quarter
ended June30, 2003 from the shareholders, all the complaints
have been resolved and no complaints were pending as on
June 30, 2003.
|
|
Place : Chennai
Date : 24-July-2003
|
For and on behalf of the Board
K.Raghavendra Rao
Managing Director
|
|
|